TFA
VIR icon

Toth Financial Advisory’s Vir Biotechnology VIR Stock Holding History

Toth Financial Advisory’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20
Closed -$491 – 852
2023
Q2 		$491 Hold
20
– – ﹤0.01% 744
2023
Q1 		$466 Sell
20
-20
-50% -$512 ﹤0.01% 775
2022
Q4 		$1.01K Hold
40
– – ﹤0.01% 662
2022
Q3 		$1K Hold
40
– – ﹤0.01% 723
2022
Q2 		$1K Hold
40
– – ﹤0.01% 676
2022
Q1 		$1K Hold
40
– – ﹤0.01% 691
2021
Q4 		$2K Hold
40
– – ﹤0.01% 668
2021
Q3 		$2K Buy
+40
New +$1.73K ﹤0.01% 678
2021
Q1 		– Sell
-120
Closed -$3K – 718
2020
Q4 		$3K Buy
120
+70
+140% +$2.27K ﹤0.01% 511
2020
Q3 		$2K Hold
50
– – ﹤0.01% 497
2020
Q2 		$2K Buy
+50
New +$1.68K ﹤0.01% 481

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Toth Financial Advisory's VIR Position: Q3 2023 in Review

Toth Financial Advisory sold out of Vir Biotechnology (VIR) in Q3 2023, closing a stake of 20 shares — an estimated $491 sold.

Toth Financial Advisory first reported a position in VIR in Q2 2020 and held it in 11 quarters. The position peaked at $3K in Q4 2020. 214 funds tracked by Wall St. Rank hold VIR as of Q3 2023.

  • Toth Financial Advisory reported no remaining Vir Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Toth Financial Advisory sold 20 Vir Biotechnology shares in Q3 2023, an estimated $491.
  • Toth Financial Advisory first reported a position in Vir Biotechnology in Q2 2020 and held it in 11 quarters.
  • Toth Financial Advisory's Vir Biotechnology position peaked at $3K in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2023.

Based on Toth Financial Advisory's 13F filing for Q3 2023, filed 12 Oct 2023.